ERIC CARANDANG: Open Payments
NPI 1629010210 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 81 payments from 18 companies in 2025. Trend: 2023 $1,180 · 2024 $771 · 2025 $1,487
Food & beverage: $1,436Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $464 |
| Janssen Biotech, Inc. | 17 | $266 |
| QOL Medical, LLC | 6 | $168 |
| Ardelyx, Inc. | 5 | $97 |
| Ipsen Biopharmaceuticals, Inc | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| GENZYME CORPORATION | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Organon LLC | 2 | $31 |
Products named: TREMFYA, RINVOQ, Sucraid, DUPIXENT, SKYRIZI, IBSRELA, LINZESS, IQIRVO.
Industry payments across SC — which companies pay providers there.
